Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Rosalind Advisors, Inc. (CIK 1622627) reported $248.9M across 30 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: DCTH ($30.6M, 12.31%), XERS ($18.7M, 7.53%), FENC ($17.9M, 7.19%), SVRA ($17.5M, 7.03%), PCVX ($16.9M, 6.77%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | DCTH | DELCATH SYSTEMS, INC. | $30.6M | 12.31% | 3.3M | Hold |
| 2 | XERS | XERIS BIOPHARMA HOLDINGS INC | $18.7M | 7.53% | 3.2M | Added |
| 3 | FENC | FENNEC PHARMACEUTICALS INC | $17.9M | 7.19% | 2.9M | Added |
| 4 | SVRA | SAVARA INC | $17.5M | 7.03% | 3.2M | Trimmed |
| 5 | PCVX | VAXCYTE INC | $16.9M | 6.77% | 290,000 | New |
| 6 | EYPT | EYEPOINT PHARMACEUTICALS INC | $13.4M | 5.37% | 1.0M | Added |
| 7 | XFOR | X4 PHARMACEUTICALS INC | $13.3M | 5.33% | 3.2M | Added |
| 8 | VOR | VOR BIOPHARMA INC | $12.5M | 5.02% | 700,000 | New |
| 9 | MDWD | MEDIWOUND LTD | $12.1M | 4.85% | 749,054 | Hold |
| 10 | VSTM | VERASTEM INC | $11.3M | 4.55% | 2.1M | Added |
| 11 | CLDX | CELLDEX THERAPEUTICS INC | $10.5M | 4.21% | 330,000 | New |
| 12 | BCRX | BIOCRYST PHARMACEUTICALS INC | $8.8M | 3.53% | 923,057 | New |
| 13 | CYBN | CYBIN INC | $7.4M | 2.95% | 1.5M | Trimmed |
| 14 | CGON | CG ONCOLOGY INC | $6.8M | 2.72% | 100,000 | Trimmed |
| 15 | NSPR | INSPIREMD INC | $6.4M | 2.56% | 3.9M | Hold |
| 16 | AVIR | ATEA PHARMACEUTICALS INC | $6.3M | 2.53% | 1.2M | New |
| 17 | PROF | PROFOUND MEDICAL CORP | $5.4M | 2.16% | 828,118 | Trimmed |
| 18 | VRDN | VIRIDIAN THERAPEUTICS INC | $4.9M | 1.97% | 250,401 | Trimmed |
| 19 | REPL | REPLIMUNE GROUP INC | $2.7M | 1.10% | 1.3M | Added |
| 20 | PYPD | POLYPID LTD | $2.6M | 1.05% | 597,926 | Trimmed |
| 21 | MYO | MYOMO INC | $2.6M | 1.04% | 3.8M | Added |
| 22 | ACRX | TALPHERA INC | $2.5M | 1.01% | 3.4M | Trimmed |
| 23 | OVID | OVID THERAPEUTICS INC | $2.5M | 0.99% | 1.1M | New |
| 24 | DEFINIUM THERAPEUTICS INC | $2.4M | 0.95% | 125,000 | New | |
| 25 | OKUR | ONKURE THERAPEUTICS INC | $1.8M | 0.74% | 443,763 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31